These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10083316)

  • 1. Expression of soluble allo-MHC class I antigen in vivo suppresses IL-2 production by allo-reactive helper T cells.
    Geissler EK; Graeb C; Jauch KW; Scherer MN
    Transplant Proc; 1999; 31(1-2):742-3. PubMed ID: 10083316
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic suppression mediated by genetically modified hepatocytes expressing secreted allo-MHC class I molecules.
    Graeb C; Scherer MN; Knechtle SJ; Geissler EK
    Hum Immunol; 1998 Jul; 59(7):415-25. PubMed ID: 9684991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte expression of soluble donor MHC class I antigen via gene transfer inhibits multiple aspects of the antidonor immune response in fully sensitized rat transplant recipients.
    Graeb C; Scherer MN; Kroemer A; Jauch KW; Geissler EK
    Hum Immunol; 2002 Oct; 63(10):948-54. PubMed ID: 12368047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for involvement of dual-function T cells in rejection of MHC class I disparate skin grafts. Assessment of MHC class I alloantigens as in vivo helper determinants.
    Rosenberg AS; Mizuochi T; Singer A
    J Exp Med; 1988 Jul; 168(1):33-45. PubMed ID: 2456372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of immunogenic and tolerogenic epitopes in the RT1.A1 alloantigen.
    Wang M; Yu J; Stepkowski SM; Kahan BD
    Transplant Proc; 1999 May; 31(3):1517-8. PubMed ID: 10330987
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
    Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex-expressing nonhematopoietic astroglial cells prime only CD8+ T lymphocytes: astroglial cells as perpetuators but not initiators of CD4+ T cell responses in the central nervous system.
    Sedgwick JD; Mössner R; Schwender S; ter Meulen V
    J Exp Med; 1991 May; 173(5):1235-46. PubMed ID: 1827142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats.
    Scherer MN; Graeb C; Tange S; Dyson C; Jauch KW; Geissler EK
    Hepatology; 2000 Nov; 32(5):999-1007. PubMed ID: 11050050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens.
    Singer A; Munitz TI; Golding H; Rosenberg AS; Mizuochi T
    Immunol Rev; 1987 Aug; 98():143-70. PubMed ID: 2958403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of alloimmunity to major histocompatibility complex class I by cotransfer of cytokine genes in vivo.
    Zhai Y; Hong X; Wang J; Fechner JH; Goodman RE; Johnson MC; Knechtle SJ
    Transpl Immunol; 1998 Sep; 6(3):169-75. PubMed ID: 9848223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immune responses by T cell subsets. Role of helper and suppressor T cells in the development and expression of MHC-restricted antibody responses to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X responder)F1 spleen cells.
    Lake JP; Kapp JA; Pierce CW
    J Immunol; 1986 Feb; 136(4):1201-9. PubMed ID: 2418108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of portal vein injection of allo-MHC-transfected hepatocytes on immunity prior to organ transplantation.
    Graeb C; Geissler EK
    Transplant Proc; 1997; 29(1-2):1017-9. PubMed ID: 9123177
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of major histocompatibility complex and non-major histocompatibility complex encoded antigens in generation of bile duct lesions during hepatic graft-vs.-host responses mediated by helper or cytotoxic T cells.
    Williams FH; Thiele DL
    Hepatology; 1994 Apr; 19(4):980-8. PubMed ID: 8138273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic T-T cell interaction present in alloreactivity: determination of 'MLR helper' T cell subsets.
    Asano Y; Komuro T; Tada T
    Int Immunol; 1990; 2(12):1203-11. PubMed ID: 1982500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta 1 derived from biliary epithelial cells may attenuate alloantigen-specific immune responses.
    Narumoto K; Saibara T; Maeda T; Onishi S; Hayashi Y; Miyazaki E; Hiroi M; Enzan H; Kobayashi N
    Transpl Int; 2000; 13(1):21-7. PubMed ID: 10743685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of the costimulatory signal in xeno-MHC-restricted helper T-cell activation.
    Iwata H; Mori Y; Takagi H; Hirota T; Iida Y; Umeda Y; Matsuno Y; Marui T; Shimabukuro K; Yoshikawa S; Hirose H
    Transplant Proc; 2002 Aug; 34(5):1453-5. PubMed ID: 12176436
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevention of early rejection by soluble MHC class I antigen after allogenic liver transplantation].
    Geissler EK; Scherer MN; Jauch KW; Graeb C
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):641-4. PubMed ID: 14518333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.